Plaque inhibition assay for drug susceptibility testing of influenza viruses.

AUTOR(ES)

Hayden, F G

RESUMO

The relative antiviral activities of four drugs against contemporary strains of influenza A and B viruses were determined in Madin-Darby canine kidney cell monolayers with a plaque inhibition assay. This assay proved to be a reliable, rapid method of determining 50% inhibitory concentrations that correlated well with clinically achievable drug levels and the results of clinical trials. Contemporary strains of influenza A viruses (subtypes H1N1, H3N2, HSW1N1) required amantadine hydrochloride and rimantadine hydrochloride 50% inhibitory concentrations in the range of 0.2 to 0.4 microgram/ml, whereas 50% inhibitory concentrations ranged from approximately 50 to 100 micrograms/ml against influenza B viruses. Ribavirin was approximately 10-fold less active than amantadine hydrochloride against influenza A viruses, and the ribavirin 50% inhibitory concentrations against both influenza A and B viruses ranged from 2.6 to 6.8 micrograms/ml. Inosiplex had no antiviral activity in this test system.

Documentos Relacionados

• Performance of the Microscopic Observation Drug Susceptibility Assay in Drug Susceptibility Testing for Mycobacterium tuberculosis
• Nitrate Reductase Assay for Drug Susceptibility Testing of Mycobacterium tuberculosis
• Phenotypic Drug Susceptibility Assay for Influenza Virus Neuraminidase Inhibitors
• Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.
• Application of the single radial diffusion test for assay of antibody to influenza type A viruses.